Addex Therapeutics (ADXN) Debt Ratio (2025)
Addex Therapeutics' (ADXN) quarterly Debt Ratio came in at 0.08 in Q4 2025.
Powered by 
Analysis
Addex Therapeutics (ADXN) Debt Ratio (2025) Analysis & Trends
Addex Therapeutics has disclosed Debt Ratio across 1 years of filings, most recently posting 0.08 for Q4 2025.
- In Q4 2025, Debt Ratio changed N/A year-over-year to 0.08; the TTM figure through Dec 2025 stood at 0.08 (changed N/A YoY), while the FY2025 annual figure was 0.08, changed N/A from the prior year.
- Debt Ratio came in at 0.08 for Q4 2025 at Addex Therapeutics.
- In the past five years, Debt Ratio ranged from a high of 0.08 in Q4 2025 to a low of 0.08 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | 0.30 |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 0.08 |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | 0.31 |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | 0.17 |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 0.00 |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | - |
| 10 | Addex Therapeutics | 3.27 Mn | 3.27 Mn | - | - |